Year-over-year earnings per share growth for the last twelve months: anteristech.com (AVR)

Public company logo of Anteris (AVR)

The quarterly EPS comparison demonstrates the potential of the leading engineering team creating the heart valves of the future at Anteris Technologies Global (AVR), with the current value equal to 55.20. Production is based in an Australian center and a climate-controlled facility in Minnesota. The startup is currently focusing on clinical trials, seeking global partners for the subsequent distribution of its medical innovations.

AVR: Anteris Year-over-year earnings per one share growth for the last 12 months 12/14/2024 - 11/15/2026

Analytical breakdowns for Anteris Technologies Global

- company stock exchange capitalization indicators:
Basic company analysis:anteristech.com - AVR
Flagship merchandise of Anteris Technologies Global

The implementation of a unique 3D valve reconstruction method in cardiology directly impacts the quarterly EPS growth of Anteris Technologies Global (AVR), which measures the percentage change in net income per share. This metric compares current financial results with the same period last year, neutralizing seasonality. By analyzing this quarterly EPS chart, an investor can gauge the speed of patent monetization. A sharp spike confirms the commercial success of the implants, while a stable trend indicates long-term business sustainability.

Who Anteris Technologies Global competes with

Regeneron Pharmaceuticals (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|LNTH (Lantheus Holdings) - Quarterly EPS earnings growth|Quarterly EPS earnings growth mineralystx.com|Year-over-year earnings per share growth for the last twelve months HeartFlow Inc (HTFL)|KMTS (Kestra Medical Technologies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Esperion Therapeutics ESPR|AMRN - Year-over-year net earnings per share growth for the last 12 months|Tenaya Therapeutics, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months CVRx, Inc. CVRX|MIST (Milestone Pharmaceuticals Inc.) - Year-over-year net earnings per share growth for the last 12 months|Cardiol Therapeutics Inc - Year-over-year earnings per one share growth for the last 12 months|BEAT (HeartBeam Corporation) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Tenax Therapeutics Inc|Quarterly EPS earnings growth ADGM|BioCardia, Inc. - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth VTAK (Catheter Precision Inc)|ABIO - Year-over-year net earnings per share growth for the last 12 months|Acasti Pharma - Quarterly EPS earnings growth|AVTE - Quarterly EPS earnings growth|VERV (vervetx.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share trend for the last twelve months WINT (Windtree Therapeutics Inc.)